Renal cell carcinoma

Current Opinion in Oncology - Tập 13 Số 3 - Trang 199-203 - 2001
Paul A. Godley1,2, Mark P. Taylor1
1University of North Carolina at Chapel Hill, Division of Hematology/Oncology, and the Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
2to Paul A. Godley, MD, PhD, University of North Carolina at Chapel Hill, Division of Hematology/Oncology, 3009 Old Clinic Building—Campus Box 7305, Chapel Hill, NC 27599-7305, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Greenlee, 2000, CA Cancer J Clin, 50, 7, 10.3322/canjclin.50.1.7

Chow, 1999, JAMA, 281, 1628, 10.1001/jama.281.17.1628

Homma, 1995, Int J Urol, 2, 77, 10.1111/j.1442-2042.1995.tb00428.x

Jayson, 1998, Urology, 51, 203, 10.1016/S0090-4295(97)00506-2

Dhote, 2000, BJU Int, 86, 20, 10.1046/j.1464-410x.2000.00708.x

Hoshida, 1999, Transplantation, 68, 385, 10.1097/00007890-199908150-00010

Schlichter, 2000, Eur Urol, 37, 517, 10.1159/000020187

Grossman, 1999, Am J Cardiol, 83, 1090, 10.1016/S0002-9149(99)00021-1

Grossman, 1999, Kidney Int, 56, 1603, 10.1046/j.1523-1755.1999.00713-3.x

Figlin, 2000, Cancer J Sci Am, 1, S52

Childs, 2000, N Engl J Med, 343, 750, 10.1056/NEJM200009143431101

Motzer, 1999, J Clin Oncol, 17, 2530, 10.1200/JCO.1999.17.8.2530

Rioux-Leclercq, 2000, Urology, 55, 501, 10.1016/S0090-4295(99)00550-6

Uhlman, 1994, J Natl Cancer Inst, 86, 1470, 10.1093/jnci/86.19.1470

Haitel, 2000, Clin Cancer Res, 6, 1840

Seliger, 2000, Int J Cancer, 87, 349, 10.1002/1097-0215(20000801)87:3<349::AID-IJC7>3.0.CO;2-O

Paradis, 2000, Virchows Arch, 436, 351, 10.1007/s004280050458

Licht, 1993, J Urol, 149, 1, 10.1016/S0022-5347(17)35982-7

Morgan, 1990, J Urol, 144, 852, 10.1016/S0022-5347(17)39608-8

Bazeed, 1986, Eur Urol, 12, 238, 10.1159/000472627

Fergany, 2000, J Urol, 163, 442, 10.1016/S0022-5347(05)67896-2

Belldegrun, 1999, J Clin Oncol, 17, 2868, 10.1200/JCO.1999.17.9.2868

Filipas, 2000, Urology, 56, 387, 10.1016/S0090-4295(00)00656-7

Dunn, 2000, J Urol, 164, 1153, 10.1016/S0022-5347(05)67131-5

Payne, 2000, J Neurosurg, 92, 760, 10.3171/jns.2000.92.5.0760

Patchell, 1998, JAMA, 280, 1485, 10.1001/jama.280.17.1485

Goyal, 2000, Int J Radiat Oncol Biol Phys, 47, 1007, 10.1016/S0360-3016(00)00536-8

Yagoda, 1993, Urol Clin North Am, 20, 303, 10.1016/S0094-0143(21)00489-4

Vogelzang, 1998, Lancet, 352, 1691, 10.1016/S0140-6736(98)01041-1

Rini, 2000, J Clin Oncol, 18, 2419, 10.1200/JCO.2000.18.12.2419

Stadler, 2000, J Clin Oncol, 18, 371, 10.1200/JCO.2000.18.2.371

Pagliaro, 2000, Cancer, 89, 615, 10.1002/1097-0142(20000801)89:3<615::AID-CNCR17>3.0.CO;2-J

Motzer, 2000, J Clin Oncol, 18, 1928, 10.1200/JCO.2000.18.9.1928

Lindsey, 2000, J Clin Oncol, 18, 1954, 10.1200/JCO.2000.18.9.1954

Fossa, 1992, Ann Oncol, 3, 301, 10.1093/oxfordjournals.annonc.a058185

Pyrhonen, 1999, J Clin Oncol, 17, 2859, 10.1200/JCO.1999.17.9.2859

Schmidinger, 2000, Anticancer Drugs, 11, 175, 10.1097/00001813-200003000-00005

Reese, 2000, Cancer, 88, 1310, 10.1002/(SICI)1097-0142(20000315)88:6<1310::AID-CNCR6>3.0.CO;2-6

Oevermann, 2000, Br J Cancer, 83, 583, 10.1054/bjoc.2000.1340

Stadler, 1998, J Clin Oncol, 16, 1820, 10.1200/JCO.1998.16.5.1820

Motzer, 2000, J Clin Oncol, 18, 2972, 10.1200/JCO.2000.18.16.2972

Ryan, 2000, Cancer, 88, 1317, 10.1002/(SICI)1097-0142(20000315)88:6<1317::AID-CNCR7>3.0.CO;2-X

Hotton, 2000, Cancer, 88, 1892, 10.1002/(SICI)1097-0142(20000415)88:8<1892::AID-CNCR19>3.0.CO;2-2

Schwaab, 2000, J Urol, 163, 1322, 10.1016/S0022-5347(05)67771-3

Figlin, 1997, J Urol, 158, 740, 10.1016/S0022-5347(01)64304-0

Figlin, 1999, J Clin Oncol, 17, 2521, 10.1200/JCO.1999.17.8.2521